BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1624220)

  • 1. Oral administration of a streptococcal agent OK-432 activates alveolar macrophages in mice.
    Kinoshita A; Suzuki I; Sakurai T; Yadomae T
    Int J Immunopharmacol; 1992 Feb; 14(2):205-11. PubMed ID: 1624220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of a streptococcal agent OK-432 activates peritoneal macrophages in mice.
    Suzuki I; Kinoshita A; Tanaka H; Yadomae T
    Int J Immunopharmacol; 1991; 13(2-3):147-54. PubMed ID: 2071291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalation therapy using a streptococcal preparation (OK-432) against bronchioloalveolar carcinoma of the lung.
    Yano T; Ichinose Y; Yokoyama H; Fukuyama Y; Sugio K; Sugimachi K
    Anticancer Res; 1999; 19(6C):5511-4. PubMed ID: 10697608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of murine alveolar macrophage functions by orally administered beta-glucan.
    Sakurai T; Hashimoto K; Suzuki I; Ohno N; Oikawa S; Masuda A; Yadomae T
    Int J Immunopharmacol; 1992 Jul; 14(5):821-30. PubMed ID: 1512075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synergistic activation of rat alveolar macrophages by cepharanthine and OK-432].
    Morioka S; Ono M; Tanaka N; Orita K
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1470-5. PubMed ID: 4015121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of some plant lectins on hydrogen peroxide release from macrophages induced with streptococcal preparation OK-432.
    Tomioka H; Saito H
    Infect Immun; 1980 May; 28(2):336-43. PubMed ID: 7399666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and augmentation of guinea pig macrophages with streptococcal preparation OK-432 and stimulated spleen cell products.
    Onozaki K; Suzuki K; Fukutomi Y; Yagami K; Hashimoto T
    J Reticuloendothel Soc; 1982 Dec; 32(6):433-42. PubMed ID: 6761439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of orally administered beta-glucan on macrophage function in mice.
    Suzuki I; Tanaka H; Kinoshita A; Oikawa S; Osawa M; Yadomae T
    Int J Immunopharmacol; 1990; 12(6):675-84. PubMed ID: 2272730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The augmentative effect of a protein-bound polysaccharide (PSK) on tumoricidal activity of the soluble factor produced by a streptococcal preparation (OK-432)-activated macrophages.
    Baba N; Kawami H; Sato Y; Takayama T; Toge T
    Biotherapy; 1991; 3(4):359-64. PubMed ID: 1786200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of interleukin 1 and interleukin 2 production by OK-432.
    Ichimura O; Suzuki S; Saito M; Sugawara Y; Ishida N
    Int J Immunopharmacol; 1985; 7(2):263-70. PubMed ID: 3874175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing pattern of the splenic lymphocyte subsets in tumor-bearing mice after oral treatment with OK-432.
    Akamatsu Y; Fuchimoto S; Orita K
    Jpn J Cancer Res; 1992 Jun; 83(6):656-60. PubMed ID: 1353756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor effects of the oral administration of the streptococcal preparation OK-432 (PICIBANIL)--the inhibition of carcinogenesis and growth in rats with ENNG-induced gastrointestinal tumors.
    Takeshita M; Makita F; Takeyoshi I; Ishikawa H; Nakamura S; Owada S; Miyamoto Y; Izuo M; Kurashige S
    Jpn J Surg; 1990 May; 20(3):316-26. PubMed ID: 2359208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally administered streptococcal preparation, OK-432 augments the antitumor immunity of patients with gastric or colorectal cancer.
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tobe T
    Biotherapy; 1990; 2(3):213-22. PubMed ID: 2206774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1-->3)-beta-D-glucan.
    Sakurai T; Kaise T; Yadomae T; Matsubara C
    Eur J Pharmacol; 1997 Sep; 334(2-3):255-63. PubMed ID: 9369356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced hydrogen peroxide release from macrophages stimulated with streptococcal preparation OK-432.
    Saito H; Tomioka H
    Infect Immun; 1979 Nov; 26(2):779-82. PubMed ID: 546795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of macrophage function by intraperitoneal administration of the streptococcal antitumor agent OK-432.
    Kawaguchi T; Suematsu M; Koizumi HM; Mitsui H; Suzuki S; Matsuno T; Ogawa H; Nomoto K
    Immunopharmacology; 1983 Oct; 6(3):177-89. PubMed ID: 6629737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan enhances IL-12 production by OK-432-activated murine macrophages.
    Zhang B; Fujimoto T; Kaneda A; Mai M
    Anticancer Res; 2003; 23(3B):2499-504. PubMed ID: 12894533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of orally administered streptococcal preparation, OK-432 on murine solid tumors and its absorption from the gut.
    Nio Y; Shiraishi T; Tsuchitani T; Tobe T; Sugawara Y; Saito M; Kamiyama H
    In Vivo; 1989; 3(5):307-13. PubMed ID: 2519870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive effects of tranilast on pulmonary fibrosis and activation of alveolar macrophages in mice treated with bleomycin: role of alveolar macrophages in the fibrosis.
    Mori H; Tanaka H; Kawada K; Nagai H; Koda A
    Jpn J Pharmacol; 1995 Apr; 67(4):279-89. PubMed ID: 7544418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.